These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38690102)

  • 21. MicroRNA-27b-3p inhibits the proliferation and invasion of cutaneous squamous cell carcinoma by targeting EGFR and MMP-13.
    Liang D; Zhang Z
    Oncol Lett; 2021 Oct; 22(4):729. PubMed ID: 34429769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Retracted] Upregulation of microRNA‑181b inhibits CCL18‑induced breast cancer cell metastasis and invasion via the NF‑κB signaling pathway.
    Wang L; Wang YX; Chen LP; Ji ML
    Oncol Lett; 2024 Jun; 27(6):268. PubMed ID: 38659419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retracted] Long non‑coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway.
    Bao H; Guo CG; Qiu PC; Zhang XL; Dong Q; Wang YK
    Oncol Lett; 2024 Dec; 28(6):553. PubMed ID: 39345721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.
    Wu W; Dang S; Feng Q; Liang J; Wang Y; Fan N
    Biochem Biophys Res Commun; 2017 Jan; 482(1):100-105. PubMed ID: 27815069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retracted] miR‑133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion.
    Zou Y; Yang J; Wu J; Luo C; Huang Y
    Oncol Lett; 2024 Apr; 27(4):175. PubMed ID: 38464341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retracted: Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian Cancer by Reducing Smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9765812. PubMed ID: 37593746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retracted: Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
    International BR
    Biomed Res Int; 2023; 2023():9798465. PubMed ID: 37388366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of MicroRNA-130a Inhibits Oral Squamous Cell Carcinoma Proliferation and Metastasis via the Hippo-YAP Pathway [Retraction].
    Cancer Manag Res; 2021; 13():8005-8006. PubMed ID: 34707407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retracted: Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9898076. PubMed ID: 37860331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
    Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
    World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9873529. PubMed ID: 36756140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
    Markers D
    Dis Markers; 2023; 2023():9861260. PubMed ID: 37387768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
    Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retracted] Total flavonoids suppress lung cancer growth via the COX‑2‑mediated Wnt/β‑catenin signaling pathway.
    Han L; Fang S; Li G; Wang M; Yu R
    Oncol Lett; 2024 Mar; 27(3):90. PubMed ID: 38268778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway.
    International BR
    Biomed Res Int; 2024; 2024():9796319. PubMed ID: 38229987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
    Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
    J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retracted: MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.
    International BR
    Biomed Res Int; 2024; 2024():9840106. PubMed ID: 38230029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma.
    Cao TT; Xiang D; Liu BL; Huang TX; Tan BB; Zeng CM; Wang ZY; Ming XY; Zhang LY; Jin G; Li F; Wu JL; Guan XY; Lu D; Fu L
    Oncotarget; 2017 Sep; 8(39):65957-65968. PubMed ID: 29029485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.